(Q85337953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

1

Ghaith Bakdash

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Toni M M van Capel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lauren M K Mason

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Martien L Kapsenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Esther C de Jong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

16 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

6294-6302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

7 January 2021

Vitamin D and the skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Vitamin D and human health: lessons from vitamin D receptor null mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Mechanism of 1α,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Primary effect of 1α,25(OH)₂D₃ on IL-10 expression in monocytes is short-term down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Immunological mechanisms of allergen-specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.075

10.1016/J.VACCINE.2014.08.075

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236584%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference